Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
55,617,707
-
Share change
-
-11,596,389
-
Total reported value
-
$7,329,471
-
Put/Call ratio
-
0.94%
-
Price per share
-
$0.13
-
Number of holders
-
86
-
Value change
-
-$4,077,724
-
Number of buys
-
13
-
Number of sells
-
45
Institutional Holders of ZIOPHARM ONCOLOGY INC - COM (TCRT) as of Q3 2023
As of 30 Sep 2023,
ZIOPHARM ONCOLOGY INC - COM (TCRT) was held by
86 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
55,617,707 shares.
The largest 10 holders included
DISCOVERY CAPITAL MANAGEMENT, LLC / CT, MSD Partners, L.P., VANGUARD GROUP INC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, Boxer Capital, LLC, STATE STREET CORP, OSAIC HOLDINGS, INC., GSA CAPITAL PARTNERS LLP, and COMMERCE BANK.
This page lists
86
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.